Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith R Neal

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
BMC Medical Research Methodology|May 7, 2010
Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study)Sarah J O'Brien, Greta Rait, Paul R Hunter, et al.
Vaccine|September 30, 2010
Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriageDlawer A A Ala'aldeen, Mike Flint, Neil J Oldfield, et al.
The Journal of Infectious Diseases|February 15, 2008
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunityMartin C J Maiden, Ana Belén Ibarz-Pavón, Rachel Urwin, et al.
The Journal of Infectious Diseases|September 2, 2011
Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementationAna Belén Ibarz-Pavón, Jenny Maclennan, Nicholas J Andrews, et al.
Lancet (London, England)|August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialRobert C Read, David Baxter, David R Chadwick, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
BMC Medical Research Methodology|May 7, 2010
Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study)Sarah J O'Brien, Greta Rait, Paul R Hunter, et al.
Vaccine|September 30, 2010
Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriageDlawer A A Ala'aldeen, Mike Flint, Neil J Oldfield, et al.
The Journal of Infectious Diseases|February 15, 2008
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunityMartin C J Maiden, Ana Belén Ibarz-Pavón, Rachel Urwin, et al.
The Journal of Infectious Diseases|September 2, 2011
Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementationAna Belén Ibarz-Pavón, Jenny Maclennan, Nicholas J Andrews, et al.
Lancet (London, England)|August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialRobert C Read, David Baxter, David R Chadwick, et al.
Pageof 4